BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 19699531)

  • 21. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.
    Farahvash MS; Majidi AR; Roohipoor R; Ghassemi F
    Retina; 2011; 31(7):1254-60. PubMed ID: 21499192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
    Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery.
    Takamura Y; Kubo E; Akagi Y
    Ophthalmology; 2009 Jun; 116(6):1151-7. PubMed ID: 19376589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of preoperative intravitreal bevacizumab on visual function in eyes with proliferative diabetic retinopathy.
    Ushida H; Kachi S; Asami T; Ishikawa K; Kondo M; Terasaki H
    Ophthalmic Res; 2013; 49(1):30-6. PubMed ID: 23038607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study.
    Arevalo JF; Sánchez JG; Wu L; Berrocal MH; Alezzandrini AA; Restrepo N; Maia M; Farah ME; Brito M; Díaz-Llopis M; Rodríguez FJ; Reategui G; Iturralde-Iraola J; Udaondo-Mirete P;
    Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
    di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
    Gupta A; Bansal R; Gupta V; Dogra MR
    Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy.
    Cho WB; Moon JW; Kim HC
    Br J Ophthalmol; 2010 Jul; 94(7):858-63. PubMed ID: 20606024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
    Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
    Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.
    Arevalo JF; Maia M; Flynn HW; Saravia M; Avery RL; Wu L; Eid Farah M; Pieramici DJ; Berrocal MH; Sanchez JG
    Br J Ophthalmol; 2008 Feb; 92(2):213-6. PubMed ID: 17965108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
    Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
    Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.
    Göncü T; Özdek S; Ünlü M
    Eur J Ophthalmol; 2014; 24(1):88-93. PubMed ID: 23787453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.
    Abdelhakim MA; Macky TA; Mansour KA; Mortada HA
    Ophthalmic Res; 2011; 45(1):23-30. PubMed ID: 20714187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2009; 29(10):1396-403. PubMed ID: 19898177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials.
    Zhang ZH; Liu HY; Hernandez-Da Mota SE; Romano MR; Falavarjani KG; Ahmadieh H; Xu X; Liu K
    Am J Ophthalmol; 2013 Jul; 156(1):106-115.e2. PubMed ID: 23791371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.